SOPHiA GENETICS and AstraZeneca Partner to Develop Two Companion Diagnostics for Precision Oncology
SOPHiA GENETICS and AstraZeneca have launched a multi-year collaboration to develop two companion diagnostics for solid tumours and blood cancers, supporting broader access to precision oncology therapies.
SOPHiA GENETICS | 18/08/2026 | By News Bureau
Sophia Genetics Signs MoU with Memorial Sloan Kettering Cancer Center
Sophia Genetics has signed a strategic collaboration Memorandum of Understanding (MoU) with Memorial Sloan Kettering Cancer Center to establish a next-generation precision medicine hub.
Sophia Genetics | 08/06/2026 | By News Bureau | 179
Sophia Genetics, MD Anderson Partner to Advance AI-Driven Precision Oncology
The strategic collaboration will combine SOPHiA GENETICS’ AI-powered analytics with MD Anderson Cancer Centre’s clinical expertise to develop next-generation sequencing tools and accelerate data-driven cancer diagnosis and treatment.
Sophia Genetics | 12/01/2026 | By News Bureau | 211
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy